List of life sciences

HCLTech Partners with Purdue Global for Higher Education Program

Retrieved on: 
Thursday, October 13, 2022

HCLTech, a leading global technology company, and Purdue Global announced a new partnership to provide HCLTech employees opportunities to further their education.

Key Points: 
  • HCLTech, a leading global technology company, and Purdue Global announced a new partnership to provide HCLTech employees opportunities to further their education.
  • HCLTech employees and its apprentices based in the United States will be able to pursue courses at Purdue Global to enhance their technology skills.
  • At HCLTech, we are driven by our purpose of supercharging the potential of our people, said Ramachandran Sundararajan, Chief People Officer, HCLTech.
  • We are thrilled to be partnering with HCLTech, a leader in next-generation global technology and an award-winning employer, in providing higher education opportunities for their employees, said Jon Harbor, Purdue Global Provost.

Mary Crowley Cancer Research Adds Ed Marx to Board of Directors

Retrieved on: 
Friday, October 14, 2022

DALLAS, Oct. 14, 2022 /PRNewswire-PRWeb/ -- Mary Crowley Cancer Research (MCCR) announced today the addition of Edward Marx to their Board of Directors. Marx currently also serves as Chief Executive Officer of Divurgent, a solutions provider focused on what matters most to their client partners.

Key Points: 
  • Mary Crowley Cancer Research (MCCR) announced today the addition of Edward Marx to their Board of Directors.
  • DALLAS, Oct. 14, 2022 /PRNewswire-PRWeb/ -- Mary Crowley Cancer Research (MCCR) announced today the addition of Edward Marx to their Board of Directors.
  • Mary Crowley Cancer Research is a specialized clinical research center in Dallas, Texas that offers access to new investigational therapies through the administration of Phase I and II clinical trials.
  • The mission of Mary Crowley Cancer Research is to bring HOPE to cancer patients through innovative clinical trials while advancing treatment globally for all patients in the future.

Harba Solutions New Approach To Life Science Staffing Wins Investment From PE Firm

Retrieved on: 
Thursday, October 13, 2022

INDIANAPOLIS, Oct. 13, 2022 /PRNewswire-PRWeb/ -- Founded in 2021, Wade saw an opportunity to bring a new approach to the Life Science staffing industry by offering a fast-paced, high-touch service that consistently delivers on its commitments. Over the last 12 months, Harba Solutions has grown to a team of 12, who deploy over 300 contractors to leading Life Science companies across the United States.

Key Points: 
  • Harba Solutions, an Indianapolis-based Life Science staffing company, announced that private equity firm, Tempting Ventures, has invested in the company just one year after Wade Franchville set up the business.
  • INDIANAPOLIS, Oct. 13, 2022 /PRNewswire-PRWeb/ -- Founded in 2021, Wade saw an opportunity to bring a new approach to the Life Science staffing industry by offering a fast-paced, high-touch service that consistently delivers on its commitments.
  • Over the last 12 months, Harba Solutions has grown to a team of 12, who deploy over 300 contractors to leading Life Science companies across the United States.
  • After seeing Harba Solutions' rapid success, Tempting Ventures recently invested in the firm to help Harba expand its offering and scale within new Life Science industries.

6-Hour Virtual Seminar on Effective Technical Writing in the Life Sciences

Retrieved on: 
Thursday, October 13, 2022

DUBLIN, Oct. 13, 2022 /PRNewswire/ -- The "6-Hour Virtual Seminar on Effective Technical Writing in the Life Sciences" webinar has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 13, 2022 /PRNewswire/ -- The "6-Hour Virtual Seminar on Effective Technical Writing in the Life Sciences" webinar has been added to ResearchAndMarkets.com's offering.
  • This seminar will begin with a general discussion of technical writing and its role within the life sciences.
  • This virtual seminar will walk you through the technical writing process from start to finish.
  • Each critical aspect of writing technical documents for the life sciences will be addressed with the goal of helping you become better technical writers.

The Cost-effectiveness and Increasing adoption of Hybrid Cloud Service is expected to proliferate the Cloud Infrastructure Service Market | UnivDatos Market Insights

Retrieved on: 
Thursday, October 13, 2022

This innovative report makes use of several analyses to get a closer outlook on the Cloud Infrastructure Service market.

Key Points: 
  • This innovative report makes use of several analyses to get a closer outlook on the Cloud Infrastructure Service market.
  • The Cloud Infrastructure Service market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the Cloud Infrastructure Service market at the global and regional levels.
  • Based on deployment, the cloud infrastructure service market is divided into public cloud, private cloud, and hybrid cloud.

The Cost-effectiveness and Increasing adoption of Hybrid Cloud Service is expected to proliferate the Cloud Infrastructure Service Market | UnivDatos Market Insights

Retrieved on: 
Thursday, October 13, 2022

This innovative report makes use of several analyses to get a closer outlook on the Cloud Infrastructure Service market.

Key Points: 
  • This innovative report makes use of several analyses to get a closer outlook on the Cloud Infrastructure Service market.
  • The Cloud Infrastructure Service market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the Cloud Infrastructure Service market at the global and regional levels.
  • Based on deployment, the cloud infrastructure service market is divided into public cloud, private cloud, and hybrid cloud.

Results from a Randomized Controlled Trial Show That TissueCypher® Barrett’s Esophagus Test Results Can Significantly Improve the Accuracy of Risk Assessments and Adherence to Guideline-Recommended Patient Management

Retrieved on: 
Thursday, October 13, 2022

TissueCypher is Castles precision medicine test designed to predict progression to HGD and/or EAC within five years for patients diagnosed with BE.

Key Points: 
  • TissueCypher is Castles precision medicine test designed to predict progression to HGD and/or EAC within five years for patients diagnosed with BE.
  • Importantly, subsequent to receiving test results and making their assessment, the intervention group was also more likely to adhere to guideline-recommended management strategies.
  • Quality-of-care scores improved significantly across all patient cases after physicians were given the TissueCypher test results.
  • The TissueCypher Barretts Esophagus test is Castles precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barretts esophagus (BE).

Walden Biosciences Announces Participation at October Investor Conferences

Retrieved on: 
Thursday, October 13, 2022

Walden Biosciences is focused on developing breakthrough medicines to treat both rare and common forms of kidney disease.

Key Points: 
  • Walden Biosciences is focused on developing breakthrough medicines to treat both rare and common forms of kidney disease.
  • Founded by world-renowned renal experts, Walden is applying novel, multi-disciplinary approaches that directly target the kidneys to prevent damage, slow disease progression, and restore kidney function.
  • Waldens programs address two novel targets for therapeutic intervention, directly targeting two cell types in the kidney: podocytes and proximal tubular cells.
  • Walden was launched in late 2020 with a $51 million Series A round of financing led by Arch Venture Partners with participation from other leading venture capital firms.

5th Year in a Row, SIA Ranks GQR #7 Fastest-Growing U.S. Staffing Firm

Retrieved on: 
Wednesday, October 12, 2022

NEW YORK, Oct. 12, 2022 /PRNewswire/ -- GQR Global Markets announced today that it has been named #7 on Staffing Industry Analysts' (SIA) 2022 List of Fastest-Growing Staffing Firms for the 5th year in a row.

Key Points: 
  • NEW YORK, Oct. 12, 2022 /PRNewswire/ -- GQR Global Markets announced today that it has been named #7 on Staffing Industry Analysts' (SIA) 2022 List of Fastest-Growing Staffing Firms for the 5th year in a row.
  • GQR specializes in supporting the healthcare, life sciences, technology and financial services sectors.
  • "We're committed to our core expertise in further supporting our existing audiences and enhancing our competitive advantage," Kent says.
  • Founded in 2009 amid the global economic crisis, GQR is also no stranger to navigating challenging economic times.

BGL Facilitates Partnership Between Chicago Cardiology Institute and Cardiovascular Associates of America

Retrieved on: 
Wednesday, October 12, 2022

CHICAGO, Oct. 12, 2022 /PRNewswire/ -- BrownGibbonsLang& Company(BGL) is pleased to announce a new partnership between Chicago Cardiology Institute (CCI), a nationally recognized cardiology practice, and Cardiovascular Associates of America (CVAUSA), a comprehensive physician management services organization.

Key Points: 
  • CHICAGO, Oct. 12, 2022 /PRNewswire/ -- BrownGibbonsLang& Company(BGL) is pleased to announce a new partnership between Chicago Cardiology Institute (CCI), a nationally recognized cardiology practice, and Cardiovascular Associates of America (CVAUSA), a comprehensive physician management services organization.
  • Chicago Cardiology Institute was founded in 2009 by Parag Doshi, MD, FACC, FSCAI.
  • CCI is complemented by Chicago Vascular Clinic (CVC), the first outpatient vascular center in Illinois with a stellar track record in advanced vascular procedures.
  • Headquartered in Orlando, Cardiovascular Associates of America aims to bring the best cardiovascular physicians into one network with the common mission of saving lives, reducing costs, and improving patient care through clinical innovation.